BIO-key International Inc. (NASDAQ:BKYI) Sees Significant Decline in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a large drop in short interest in August. As of August 14th, there was short interest totaling 13,765 shares, a drop of 78.5% from the July 30th total of 63,876 shares. Currently, 1.0% of the shares of the stock are short sold. Based on an average trading volume of 111,165 shares, the days-to-cover ratio is presently 0.1 days.

Analysts Set New Price Targets

A number of analysts have recently commented on BKYI shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. Zacks Research raised BIO-key International to a “hold” rating in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, BIO-key International has an average rating of “Reduce”.

BIO-key International Trading Up 1.7%

Shares of BIO-key International stock opened at $3.02 on Wednesday. The firm has a market capitalization of $4.35 million, a PE ratio of -0.73 and a beta of 0.44. The firm’s 50 day moving average is $4.20 and its 200 day moving average is $5.05. BIO-key International has a 1 year low of $2.88 and a 1 year high of $19.70.

BIO-key International (NASDAQ:BKYI) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%.The business had revenue of $1.92 million for the quarter, compared to analyst estimates of $1.80 million. As a group, research analysts anticipate that BIO-key International will post -1.62 earnings per share for the current year.

Hedge Funds Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC increased its holdings in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. Institutional investors and hedge funds own 26.51% of the company’s stock.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.